IndraLab

Statements


RAS binds KRAS and RAF1. 5 / 5
| 5

sparser
"Structural superposition of WT KRAS-RBDCRD with all three mutant structures shows similar interaction interfaces, suggesting that the two RAS-binding domains of RAF1 bind to oncogenic KRAS mutants similarly to WT KRAS (Fig.  xref )."

sparser
"In fact, the interaction between these two proteins was first described in a Y2H screening and largely occurs through interaction of the N-terminal (aa 56–131) Ras-binding domain (RBD) of CRAF and the effector-binding domain of KRAS (aa 32–40) in a GTP-dependent manner ( xref , xref )."

sparser
"Subsequent interaction of the RAF1 RAS binding domain with KRAS does not significantly change G-domain configurations on the membrane but affects their relative populations."

sparser
"KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation."

sparser
"Analysis of the canonical RAS-RAF-MEK-ERK signaling cascade ( xref ) after reversion of the mesenchymal H157 and H1155 KRAS mutant cells to an epithelial state through induced, stable, or transient expression of miR-200, showed an increase in KRAS binding to the RAS binding domain (RBD) of RAF1 (CRAF), followed by activation of MAPK signaling ( xref and xref , xref )."